DLH Holdings Corp.’s subsidiary Social & Scientific Systems, Inc. has been awarded an indefinite delivery, indefinite quantity multiple award contract to provide support to the National Cancer Institute’s Division of Cancer Epidemiology and Genetics.
The contract has a 5-year base period and a 5-year extension option, and in aggregate has a $320 million ceiling for all awardees.
“DLH is thrilled for the opportunity to build upon our partnership with the renowned researchers of DCEG as we aim to discover the genetic and environmental determinants of cancer and find new approaches to preventing the disease,” said Jeanine Christian, president of DLH’s public health and scientific research operating unit.
Through Social & Scientific Systems, Inc., DLH has won a seat on all task areas covered by the IDIQ, and will compete for individual task orders across the contract. Responsibilities include managing multidisciplinary domestic and international studies with diverse study designs of varying sizes and complexities.
“Our proven experience in simultaneously executing multiple complex epidemiologic studies, managing sites, and coordinating with support networks across the globe with rapid start-up and adaptability enables DLH to jump right into this potentially life-saving work,” Christian said.
DLH President and CEO Zach Parker added that the contract vehicle positions DLH to expand its support for what he called “the great global public health missions of our time,” the battle against cancer.
“To carry out this vital work, DLH will leverage a deep roster of highly credentialed staff, a ready-to-tap domestic and international network for rapid operational and technical support, and the latest technology and forward-thinking data processes,” he said.
